Overactive Bladder - Results from #860

Velicept Therapeutics Announces Positive Top-Line Phase 2b Results for Solabegron in the Treatment of Overactive Bladder (OAB) March 28, 2019

Association between the Urinary Bladder Volume and the Incidence of "De Novo" Overactive Bladder in Patients with Stress Urinary Incontinence Subjected to Sling Surgeries or Burch Procedure. March 24, 2019

Randomized, open-label, tolterodine-controlled, comparative study of the novel antimuscarinic agent imidafenacin in patients with overactive bladder. March 24, 2019

Urovant Sciences Announces Positive Topline Results from Pivotal Phase 3 EMPOWUR Study of Vibegron in Patients with Overactive Bladder March 20, 2019

Using a checklist to increase the effectiveness of behavioral therapy for overactive bladder: A prospective randomized controlled trial. March 17, 2019

Clinical and urodynamic impact of detrusor overactivity in women with overactive bladder. March 17, 2019

Even Younger Nightshift Workers Showing Signs of Frequent Urination, Worsening Quality of Life March 15, 2019

"A secret club": focus groups about women's toileting behaviors. March 10, 2019

Remotely programmed sacral neuromodulation for the treatment of patients with refractory overactive bladder: a prospective randomized controlled trial evaluating the safety and efficacy of a novel sacral neuromodulation device. March 10, 2019

The effect of bladder filling rate on the voiding behaviour of patients with overactive bladder. March 3, 2019

Abdominal versus Standard Placement of the Sacral Nerve Stimulator Implantable Pulse Generator. February 24, 2019

Which antimuscarinic agents used in the treatment of overactive bladder increase heart rate? a prospective randomized clinical trial. February 24, 2019

Characterizing the Health-Related Quality of Life Burden of Overactive Bladder Using Disease-Specific Patient-Reported Outcome Measures: A Systematic Literature Review. February 17, 2019

Predictors for De Novo Overactive Bladder after Readjustable Mid-Urethral Sling Procedure in Women with Stress Urinary Incontinence due to Intrinsic Sphincter Deficiency. February 17, 2019

Do Patients Discontinue Overactive Bladder Medications After Sacral Neuromodulation? February 10, 2019

Understanding overactive bladder and urgency incontinence: what does the brain have to do with it? February 10, 2019

Evaluation of real-world persistence of propiverine and trospium chloride in treatment of overactive bladder in Germany. February 3, 2019

Efficacy and safety of non-ablative vaginal erbium:YAG laser treatment as a novel surgical treatment for overactive bladder syndrome: comparison with anticholinergics and β3-adrenoceptor agonists. February 3, 2019

Overactive Bladder Symptoms After Pelvic Organ Prolapse Repair. February 3, 2019

Is the development of clinical practice guidelines for non-neurogenic overactive bladder trustworthy? A critical appraisal using the AGREE II instrument. January 27, 2019

Page 44 of 122